Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
Technical Innovations & Patient Support in Radiation Oncology|January 19, 2026
From BERT to GPT-4: A systematic review of AI-Driven toxicity extraction and grading in radiation oncologyFederico Mastroleo, Mariana Borras-Osorio, Shiv P Patel, et al.
Journal of Studies on Alcohol and Drugs|June 12, 2009
A randomized clinical trial evaluating a combined alcohol intervention for high-risk college studentsRob Turrisi, Mary E Larimer, Kimberly A Mallett, et al.
Clinical and Translational Radiation Oncology|September 18, 2024
Half body irradiation (HBI) for bone metastases in the modern radiotherapy technique era - A systematic reviewMateusz Bilski, Katarzyna Konat-Bąska, Federico Mastroleo, et al.
Journal of Substance Abuse Treatment|July 24, 2018
A sequential analysis of motivational interviewing technical skills and client responsesM Barton Laws, Molly Magill, Nadine R Mastroleo, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|April 1, 2025
Fogarty-Funded Research Ethics Education in Latin America and the Caribbean: Progress Despite Ongoing ChallengesTimothy Daly, Ignacio Mastroleo, Luis L García Valiña, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 5, 2026
Understanding retention in radiation oncology: quantitative findings from the retention survey by the ESTRO Early Career CommitteeDylan Callens, Jolien Heukelom, Amanda Webster, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2024
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
Pageof 22